More articles from Emerging Therapies: Drugs and Regimens

Open Access
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study
Lawrence Blonde, Julio Rosenstock, Juan Frias, Andreas L. Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, Vanita R. Aroda

Diabetes Care Mar 2021, 44 (3) 774-780; DOI: 10.2337/dc20-2023
Open Access
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
Juan P. Frias, Enzo Bonora, Luis Nevarez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Milicevic, Raleigh Malik, M. Angelyn Bethel, David A. Cox

Diabetes Care Mar 2021, 44 (3) 765-773; DOI: 10.2337/dc20-1473
Open Access
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes
Eva Svehlikova, Ines Mursic, Thomas Augustin, Christoph Magnes, David Gerring, Jan Jezek, Daniela Schwarzenbacher, Maria Ratzer, Michael Wolf, Sarah Howell, Leon Zakrzewski, Martina Urschitz, Bernd Tschapeller, Christina Gatschelhofer, Franz Feichtner, Fiona Lawrence, Thomas R. Pieber

Diabetes Care Feb 2021, 44 (2) 448-455; DOI: 10.2337/dc20-1017
Open Access
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial
Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar, Anne C. Hesp, Peter J. Greasley, Cecilia Karlsson, Ann Hammarstedt, Niki Arya, Daniël H. van Raalte, Hiddo J.L. Heerspink

Diabetes Care Feb 2021, 44 (2) 440-447; DOI: 10.2337/dc20-2604
You have access
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Muhammad Abdul-Ghani, Curtiss Puckett, John Adams, Ahmad Khattab, Gozde Baskoy, Eugenio Cersosimo, Curtis Triplitt, Ralph A. DeFronzo

Diabetes Care Feb 2021, 44 (2) 433-439; DOI: 10.2337/dc20-0978
You have access
The Impact of Bariatric Surgery on Incident Microvascular Complications in Patients With Type 2 Diabetes: A Matched Controlled Population-Based Retrospective Cohort Study
Pushpa Singh, Nicola Adderley, Anuradhaa Subramanian, Krishna Gokhale, Rishi Singhal, Konstantinos A. Toulis, Srikanth Bellary, Krishnarajah Nirantharakumar, Abd A. Tahrani

Diabetes Care Jan 2021, 44 (1) 116-124; DOI: 10.2337/dc20-0571
You have access
Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL⁻¹ and Insulin Degludec 100 units · mL⁻¹ in Type 1 Diabetes
Paola Lucidi, Paola Candeloro, Patrizia Cioli, Anna Marinelli Andreoli, Chiara Pascucci, Angela Gambelunghe, Geremia B. Bolli, Carmine G. Fanelli, Francesca Porcellati

Diabetes Care Jan 2021, 44 (1) 125-132; DOI: 10.2337/dc20-1033
Open Access
Randomized Double-Blind Clinical Trial Comparing Ultra Rapid Lispro With Lispro in a Basal-Bolus Regimen in Patients With Type 2 Diabetes: PRONTO-T2D
Thomas Blevins, Qianyi Zhang, Juan P. Frias, Hideaki Jinnouchi, Annette M. Chang

Diabetes Care Dec 2020, 43 (12) 2991-2998; DOI: 10.2337/dc19-2550
Open Access
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan, Elisabetta Lovati, Antonio Rossi, Ida Pastore, Marco Dell’Acqua, Elio Ippolito, Cristiana Scaranna, Rosalia Bellante, Silvia Galliani, Alessandro Roberto Dodesini, Giuseppe Lepore, Francesca Geni, Roberta Maria Fiorina, Emanuele Catena, Angelo Corsico, Riccardo Colombo, Marco Mirani, Carlo De Riva, Salvatore Endrio Oleandri, Reza Abdi, Joseph V. Bonventre, Stefano Rusconi, Franco Folli, Antonio Di Sabatino, Gianvincenzo Zuccotti, Massimo Galli, Paolo Fiorina

Diabetes Care Dec 2020, 43 (12) 2999-3006; DOI: 10.2337/dc20-1521
You have access
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial
Ian J. Neeland, Bjorn Eliasson, Takatoshi Kasai, Nikolaus Marx, Bernard Zinman, Silvio E. Inzucchi, Christoph Wanner, Isabella Zwiener, Brian S. Wojeck, Henry K. Yaggi, Odd Erik Johansen

Diabetes Care Dec 2020, 43 (12) 3007-3015; DOI: 10.2337/dc20-1096

Main menu

User menu

Search

More articles from Emerging Therapies: Drugs and Regimens

Pages

Navigate

More Information

Other ADA Resources